ACM Research ACMR Excess tax benefits associated with employee equity plans (in percent)

Excess tax benefits associated with employee equity plans (in percent) at other companies

PlexusPLXS

-2.1%-5.5pp

Jazz PharmaceuticalsJAZZ

-0.8%—

AeroVironmentAVAV

-7.6%-8.3pp

ACM ResearchACMR

-4.4%—

Charles River LaboratoriesCRL

2.6%+2.5pp

Veeva SystemsVEEV

-1.4%—

Other financials

Income statement

See full

Revenue$231.3M+34.2%

Gross profit$107.2M+29.9%

Operating income$36.2M+40.3%

Net income$17.3M-15.1%

EPS (diluted)$0.24-20.0%

Balance sheet

See full

Cash & equivalents$894.1M+91.1%

Total debt$323.8M+91.3%

Total equity$1.6B+66.6%

Total assets$3.1B+58.5%

Cash flow

See full

Operating cash flow-$29.5M-659%

CapEx$22.2M+32.7%

Free cash flow-$51.7M-352%

Valuation

See full

Market cap$7.59B+75.5%

Enterprise value$7.02B+71.6%

P/E83.4×+42.8×

P/S7.9×+2.5×

Profitability

See full

Gross margin44.2%-5.0pp

Operating margin12.5%-6.4pp

Net margin9.5%-3.8pp

FCF margin-1.1%-0.5pp

Returns & leverage

See full

Return on equity7.2%-5.0pp

Debt / equity0.2×0.0×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by ACM Research in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent.

The official record: ACM Research’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about ACM Research's excess tax benefits associated with employee equity plans (in percent).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ACM Research's excess tax benefits associated with employee equity plans (in percent)?: ACM Research (ACMR) reported excess tax benefits associated with employee equity plans (in percent) of -4.4% in Q4 2025.
What does excess tax benefits associated with employee equity plans (in percent) mean?: The percentage impact of excess tax benefits from share-based payment awards on the company's effective tax rate. It measures the relative contribution of equity plan tax treatment to the overall tax burden.